A randomized controlled trial of sublingual immunotherapy for japanese cedar pollinosis

International Archives of Allergy and Immunology

Volumn 146, Issue 1, 2008, Pages 76-84

  Horiguchi, Shigetoshi ^a   Okamoto, Yoshitaka ^a   Yonekura, Syuji ^a   Okawa, Toru ^a   Yamamoto, Heizaburou ^a   Kunii, Naoki ^a   Sakurai, Daijyu ^a   Fujimura, Takashi ^a   Nakazawa, Kazuyoshi ^b   Yasueda, Hiroshi ^c  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Allergic rhinitis; Clinical trial; Specific Immunotherapy; T cell clone; Th2

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; JAPANESE CEDAR POLLEN EXTRACT; PLACEBO; POLLEN EXTRACT; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ASTHMA; CELL CLONE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; JAPANESE CEDAR; MAJOR CLINICAL STUDY; MALE; MOUTH PAIN; ORAL PRURITUS; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYMPTOM; TH2 CELL; TREATMENT DURATION; URTICARIA;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; CLONE CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; MALE; PLANT PROTEINS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TH2 CELLS;

EID: 42449148796     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112506     Document Type: Article

References (37)

1. Bousquet J, van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:s147-s334.
2. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
3. Okuda M: Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003;91:288-296.
4. Kaneko Y, Motohashi Y, Nakamura H, Endo T, Eboshida A: Increasing prevalence of Japanese cedar pollinosis: a meta-regression analysis. Int Arch Allergy Immunol 2005;136:365-371.
5. Ito Y, Takahashi Y, Fujita T, Fukuyama S: Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination. Auris Nasus Larynx 1997;24:163-170.
6. Ito H, Nishimura J, Suzuki M, Mamiya S, Sato K, Takagi I, Baba S: Specific IgE to Japanese cypress (Chamaecyparis obtusa) in patients with nasal allergy. Ann Allergy Asthma Immunol 1995;74:299-303.
7. Katelaris CH, Burke TV, Byth K: Spatial variability in the pollen count in Sydney, Australia: can one sampling site accurately reflect the pollen count for a region? Ann Allergy Asthma Immunol 2004;93:131-136.
8. Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D; Immune Tolerance Network Group: Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006;355:1445-1455.
9. Valovirta E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J: Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006;61:1177-1183.
10. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434-440.
11. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR: Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-269.
12. Walker SM, Varney VA, Gaga M, Jacobson MR, Durham SR: Grass pollen immunotherapy: efficacy and safety during a 4-year follow up study. Allergy 1995;50:405-413.
13. Dolz I, Martinez-Cocera C, Bartolome JM, Cimarra M: A double-blind placebo-controlled study of immunotherapy with grasspollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 1996;51:489-500.
14. Okuda M: A long-term follow-up study after discontinuation of immunotherapy for Japanese cedar pollinosis. Arerugi 2006;55:655-661.
15. Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC: Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87(suppl 1):47-55.
16. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117:1021-1035.
17. Burastero SE: Sublingual immunotherapy for allergic rhinitis: an update. Curr Opin Otolaryngol Head Neck Surg 2006;14:197-201.
18. Passalacqua G, Lombardi C, Guerra L, Compalati E, Fumagalli F, Canonica GW: Sublingual immunotherapy: no more doubts. Allerg Immunol (Paris) 2005;37:314-320.
19. Wilson DR, Lima MT, Durham SR: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12.
20. Bousquet J, Demoly P: Specific immunotherapy - an optimistic future. Allergy 2006;61:1155-1158.
21. Larsen TH, Poulsen LK, Melac M, Combebias A, Andre C, Malling HJ: Safety and tolerability of grass pollen tablets in sublingual immunotherapy: a phase-1 study. Allergy 2006;61:1173-1176.
22. Hirahara K, Tatsuta T, Takatori T, Ohtsuki M, Kirinaka H, Kawaguchi J, Serizawa N, Taniguchi Y, Saito S, Sakaguchi M, Inouye S, Shiraishi A: Preclinical evaluation of an immunotherapeutic peptide comprising 7 Tcell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. J Allergy Clin Immunol 2001;108:94-100.
23. Ohkubo K, Takizawa R, Gotoh M, Okuda M: Experience of specific immunotherapy with standardized Japanese cedar pollen extract. Arerugi 2001;50:520-527.
24. Yasueda H, Akiyama K, Maeda Y, Hayakawa T, Kaneko F, Hasegawa M, Shida T: An enzyme-linked immunosorbent assay (ELISA) for the quantitation of sugi pollen and Dermatophagoides mite allergens and its application for standardization of allergen extracts. Arerugi 1991;40:1218-1225.
25. Wilson DR, Lima MT, Durham SR: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12.
26. Okuda M: Grading the severity of allergic rhinitis for treatment strategy and drug study purposes. Curr Allergy Asthma Rep 2001;1:235-241.
27. Yasueda H, Yui Y, Shimizu T, Shida T: Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria Japonica) pollen. J Allergy Clin Immunol 1983;71:77-86.
28. Delaunay J, Sasajima H, Okamoto Y, Yokota M: Side-by-side comparison of automatic pollen counters for use in pollen information system. Ann Allergy Asthma Immunol 2007;98:553-558.
29. La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW: Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-432.
30. Pajno GB, Morabito L, Barberio G: Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55:842-849.
31. Lima MT, Wilson D, Pitkin L, Roberts A, Nouri-Aria K, Jacobson M: Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002;32:507-514.
32. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L: Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006;61:151-165.
33. Frati F, Incorvaia C, Marcucci F, Sensi L, Di Cara G, Puccinelli P, Dal Bo S: Dose dependence of efficacy but not of safety in sublingual immunotherapy. Monaldi Arch Chest Dis 2006;65:38-40.
34. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA: IL-10 and TGF-βcooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-1214.
35. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, Kegel C, Disch R, Schmidt-Weber CB, Blaser K, Akdis CA: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-1575.
36. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 2006;117:433-442.
37. Sun JB, Cuburu N, Blomguist M, Li BL, Czerkinsky C, Holmgren J: Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+ CD25+ CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Scand J Immunol 2006;64:251-259.